Education
About Us
Working with TipRanks
Follow Us
Surgical Innovations (GB:SUN)
LSE:SUN
Total Valuation
Surgical Innovations has a market cap or net worth of £4.66M. The enterprise value is 5.13M.
Market Cap£4.66M
Enterprise Value5.13M
Share Statistics
Surgical Innovations has 932,816,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding932,816,160
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Surgical Innovations’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -3.49%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-3.49%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee150.18K
Profits Per Employee-6.36K
Employee Count80
Asset Turnover0.84
Inventory Turnover3.10
Valuation Ratios
The current PE Ratio of Surgical Innovations is -11.00. Surgical Innovations’s PEG ratio is 0.04.
PE Ratio-11.00
PS Ratio0.83
PB Ratio0.53
Price to Fair Value0.53
Price to FCF-19.43
Price to Operating Cash Flow13.99
PEG Ratio0.04
Income Statement
In the last 12 months, Surgical Innovations had revenue of 12.01M and earned -509.00K in profits. Earnings per share was 0.00.
Revenue12.01M
Gross Profit3.17M
Operating Income-615.00K
Pretax Income-728.00K
Net Income-509.00K
EBITDA161.00K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -15.00K and capital expenditures -420.00K, giving a free cash flow of -435.00K billion.
Operating Cash Flow-15.00K
Free Cash Flow-435.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Surgical Innovations pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.18
52-Week Price Change4.00%
50-Day Moving Average0.54
200-Day Moving Average0.59
Relative Strength Index (RSI)44.63
Average Volume (3m)599.59K
Important Dates
Surgical Innovations upcoming earnings date is Sep 23, 2025, TBA Not Confirmed.
Last Earnings DateMar 20, 2025
Next Earnings DateSep 23, 2025
Ex-Dividend Date―
Financial Position
Surgical Innovations as a current ratio of 2.32, with Debt / Equity ratio of 9.11%
Current Ratio2.32
Quick Ratio1.23
Debt to Market Cap0.15
Net Debt to EBITDA2.80
Interest Coverage Ratio-4.66
Taxes
In the past 12 months, Surgical Innovations has paid -219.00K in taxes.
Income Tax-219.00K
Effective Tax Rate0.30
Enterprise Valuation
Surgical Innovations EV to EBITDA ratio is 37.56, with an EV/FCF ratio of -21.00.
EV to Sales0.50
EV to EBITDA37.56
EV to Free Cash Flow-21.00
EV to Operating Cash Flow15.12
Balance Sheet
Surgical Innovations has £232.00K in cash and marketable securities with £2.11M in debt, giving a net cash position of £679.00K billion.
Cash & Marketable Securities£232.00K
Total Debt£2.11M
Net Cash£679.00K
Net Cash Per Share<£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is 27.75%, with operating margin of -5.12%, and net profit margin of -4.24%.
Gross Margin27.75%
Operating Margin-5.12%
Pretax Margin-6.06%
Net Profit Margin-4.24%
EBITDA Margin1.34%
EBIT Margin-4.96%
Analyst Forecast
The average price target for Surgical Innovations is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―